A new report from ISMP Canada shares what doctors, pharmacists, anaesthesiologists and others should do about the increased risk of aspiration after anesthesia for people taking GLP-1 receptor agonists like semaglutide.
Public formularies are starting to cover biosimilar insulins instead of their reference biologic drugs and it is predicted that this will save millions of dollars annually.
Healthcare providers should discuss all available treatment options that have evidence of benefit with individuals living with type 1 diabetes, including DIY options.
Sodium–glucose cotransporter-2 inhibitors may also reduce gout-related emergency department visits and hospitalizations, as well as provide cardiovascular benefits.
Diets high in saturated fat can cause neuro-inflammation responsible for depressive and anxiety disorders. The risk is increased when obesity is accompanied by metabolic dysfunctions.
